Daniel M. Shapiro
Columbia University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Daniel M. Shapiro.
Experimental Biology and Medicine | 1953
L. S. Dietrich; Daniel M. Shapiro
Summary 1. Mice receiving a vit. B6 deficient-high protein diet were observed to have significantly lower transaminase, dopa decarboxylase and cysteine desulfhydrase activities as compared to similar animals receiving an identical diet supplemented with pyridoxine. Cysteine desulfhydrase was the most sensitive to vit. B6 deprivation, followed by transaminase and dopa decarboxylase. 2. The administration of desoxypyridoxine to mice receiving an ad libitum stock diet containing adequate vit. B6 significantly decreased transaminase and dopa decarboxylase activity. However, cysteine desulfhydrase activity was uninhibited. 3. A possible explanation of the observed results is discussed, the potentialities of vitamin antagonists as precise chemotherapeutic agents being indicated.
Experimental Biology and Medicine | 1952
Daniel M. Shapiro; Jacob Kream; L. S. Dietrich
Summary 1. 2-Amino-4-hydroxy-6-formyl pteridine (6-formylpteridine), although non-carcinostatic by itself, augmented the carcinostatic action of 8-azaguanine against a mammary adenocarcinoma. This effect was found to be dependent upon a time interval between the injection of 6-formylpteridine and 8-azaguanine. 2. 6-Formylpteridine inhibited the in vitro deamination of 8-azaguanine by tumor extracts. Pre-incubation of enzyme with inhibitor was found to be essential for maximal inhibition. 3. It was postulated that the enhanced carcinostatic effect observed in vivo could be due to inhibition of 8-azaguanine deamination by 6-formylpteridine, since the deaminated product (8-azaxanthine) is non-carcinostatic. We wish to express our appreciation to Dr. J. M. Ruegsegger of the Lederle Laboratories, Pearl River, N. Y., for supplies of 8-azaguanine, and to Drs. R. O. Roblin, Jr., and J. M. Smith, Jr., of the American Cyanamid Co., Stamford, Conn., and Bound Brook, N. J., for 6-formylpteridine. We wish to acknowledge the technical assistance of Miss R. Fugmann, Miss P. Hayworth, Miss A. Atti, and Mrs. E. Zanar.
Experimental Biology and Medicine | 1956
L. S. Dietrich; Daniel M. Shapiro
Summary Omega-methylpantethine was observed markedly to inhibit sulfanilamide acetylation at concentrations which were ineffective against citrate formation in pigeon liver homogenates. With aliquots of the same homogenate. bis- beta-pantoylaminoethyl) disulfide was observed to inhibit citrate formation at concentrations which were ineffective against sulfanilamide acetylation. In either case, higher concentrations of these compounds were effective in inhibiting both systems.
Cancer Research | 1950
Alfred Gellhorn; Morris Engelman; Daniel M. Shapiro; Samuel Graff; H. B. Gillespie
Cancer Research | 1956
Daniel M. Shapiro; L. S. Dietrich; Maurice E. Shils; A. Atti; E. Borries; Ruth A. Fugmann; V. Muller; P. Hayworth; E. Zanar
Cancer Research | 1951
Daniel M. Shapiro; Alfred Gellhorn
Cancer Research | 1953
Daniel M. Shapiro; L. S. Dietrich; Maurice E. Shils; A. Atti; E. Borries; Ruth A. Fugmann; V. Muller; P. Hayworth; E. Zanar
Cancer Research | 1952
Daniel M. Shapiro
Cancer Research | 1953
L. S. Dietrich; Daniel M. Shapiro
Journal of the National Cancer Institute | 1957
Daniel M. Shapiro; Ruth A. Fugmann